<?xml version="1.0" encoding="UTF-8"?>
<p id="Par41">The study designs of the 76 articles included were systematic review (
 <italic>n</italic> = 1), narrative reviews (
 <italic>n</italic> = 19), randomised controlled trials (
 <italic>n</italic> = 7), other randomised trials (
 <italic>n</italic> = 8; of which seven were stepped-wedge trials), case-control study (
 <italic>n</italic> = 1), cohort studies (
 <italic>n</italic> = 3), cross-sectional study (
 <italic>n</italic> = 1), time-in-motion study (
 <italic>n</italic> = 1), qualitative studies (
 <italic>n</italic> = 15) and editorial, comments or other ‘opinion’ pieces (
 <italic>n</italic> = 20) (Additional file 
 <xref rid="MOESM2" ref-type="media">2</xref>). Most articles presented challenges and solutions identified during the Ebola virus epidemic in 2014 to 2016 and/or during the H1N1 pandemic in 2009. Some articles focused on more than one type of outbreak (Table 
 <xref rid="Tab2" ref-type="table">2</xref>). The studies which used an experimental design (e.g. RCTs) were reporting solutions implemented to deliver the intervention. Most articles related to clinical research responses set in lower-middle-income countries (LMICs) in Africa (
 <italic>n</italic> = 37), Latin America and the Caribbean (
 <italic>n</italic> = 3) and Asia (
 <italic>n</italic> = 1). Thirteen articles related to research responses in higher-income countries (HICs), and 22 articles focused on a global perspective. Most articles addressed more than one PEARLES domains (Fig. 
 <xref rid="Fig2" ref-type="fig">2</xref>). 
</p>
